SIIC IIT Kanpur Joins Hands with Boehringer Ingelheim India for Dementia Care Innovation

The Startup Incubation and Innovation Centre (SIIC) at IIT Kanpur has entered into a MoU with Boehringer Ingelheim India to develop innovative solutions for dementia care. Know details here

The Startup Incubation and Innovation Centre (SIIC) at the Indian Institute of Technology Kanpur (IITK) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India to advance solutions in dementia care. Boehringer Ingelheim India's team, including Managing Director Gagandeep Singh Bedi and Director of Government and Public Affairs, Corporate Affairs Prabhat Sinha, visited SIIC, and IIT Kanpur to strengthen their partnership in fostering healthcare innovations.

The MoU was exchanged between Prof. Ankush Sharma, Professor-in-Charge of SIIC at IIT Kanpur, and Gagandeep Singh Bedi, Managing Director of Boehringer Ingelheim India. Upon signing the MoU, Prof. Ankush Sharma, Professor-in-Charge, SIIC, IIT Kanpur, emphasized the far-reaching effect of this support, stating, “SIIC, IITK is home to medical technologies with a strong social impact. Boehringer Ingelheim's support aligns perfectly with our vision to create a healthy India for all. It enables us to empower the startup community, fostering an ecosystem of innovation and collaboration. Together, we are not just dreaming of a better future, we are actively building it.”

Boehringer Ingelheim's grant is aiding Manastik Technologies, a startup incubated at SIIC, IIT Kanpur, in developing India's first tele-neurorehabilitation app for dementia care and diagnosis. Utilizing DADT technology, the app provides personalized assistance from doctors and neurohealthcare professionals, tackling the increasing burden of dementia and mental health disorders in India.

The grant will facilitate the app's validation, raise awareness, and support nationwide dementia screening campaigns. Previously, in 2023, Boehringer Ingelheim backed Lenek Technologies, another SIIC-incubated startup, in enhancing Tuberculosis screening with a handheld X-ray device.

Highlighting the significance of this partnership, Gagandeep Singh Bedi, Managing Director, Boehringer Ingelheim India, said, "Our second collaboration with IIT Kanpur reinforces our belief in the power of collective innovation. We bring together scientific communities, patients and healthcare systems to develop new, holistic, and sustainable breakthrough therapies that address healthcare's greatest challenges.”

The longstanding partnership between Boehringer Ingelheim and SIIC, IIT Kanpur, highlights their mutual commitment to promoting socially beneficial technologies. This visit not only supports the startup Manastik but also fosters interaction between Boehringer Ingelheim and other healthcare startups at SIIC, paving the way for potential future collaborations.

Read More

• IIT Kanpur's F.I.R.S.T Signs MoU with ASEAN Economic Forum to Enhance Southeast Asia's Startup Ecosystem
• IIT Kanpur Empowers Rural Students with Five-Day Electronics and Arduino Workshop